DK0617611T3 - Oral, osmotisk indretning - Google Patents

Oral, osmotisk indretning

Info

Publication number
DK0617611T3
DK0617611T3 DK93901940.2T DK93901940T DK0617611T3 DK 0617611 T3 DK0617611 T3 DK 0617611T3 DK 93901940 T DK93901940 T DK 93901940T DK 0617611 T3 DK0617611 T3 DK 0617611T3
Authority
DK
Denmark
Prior art keywords
wall
support material
fibrous support
mouth
passage
Prior art date
Application number
DK93901940.2T
Other languages
English (en)
Inventor
David Emil Edgren
Gurdish Kaur Bhatti
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK0617611T3 publication Critical patent/DK0617611T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93901940.2T 1991-12-18 1992-12-18 Oral, osmotisk indretning DK0617611T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/809,741 US5200194A (en) 1991-12-18 1991-12-18 Oral osmotic device

Publications (1)

Publication Number Publication Date
DK0617611T3 true DK0617611T3 (da) 1996-05-20

Family

ID=25202119

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93901940.2T DK0617611T3 (da) 1991-12-18 1992-12-18 Oral, osmotisk indretning

Country Status (11)

Country Link
US (1) US5200194A (da)
EP (1) EP0617611B1 (da)
JP (1) JPH07506806A (da)
AT (1) ATE133561T1 (da)
AU (1) AU3333393A (da)
DE (1) DE69208104T2 (da)
DK (1) DK0617611T3 (da)
ES (1) ES2082626T3 (da)
MX (1) MX9207402A (da)
WO (1) WO1993011748A1 (da)
ZA (1) ZA929848B (da)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
EP0794769A4 (en) * 1994-12-05 1999-02-24 Peatey Phillip METHOD FOR DISPENSING DRUGS AND COATINGS FOR USE IN THIS METHOD
AU691376B2 (en) * 1994-12-05 1998-05-14 Pauli, Gunter Method of drug delivery and coatings for use in the method
US5772640A (en) 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
US6074662A (en) * 1995-08-15 2000-06-13 Montgomery; Robert E. Proteinaceous animal chew with dentally therapeutic cation
FR2747570B1 (fr) * 1996-04-19 1998-07-24 Dogself Composition a effet antitartre et son utilisation dans des complements alimentaires pour animaux
US6030358A (en) * 1997-08-08 2000-02-29 Odland; Rick Matthew Microcatheter and method for site specific therapy
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
JP3718341B2 (ja) 1998-05-12 2005-11-24 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースとその製造方法
AU4802099A (en) * 1998-07-28 2000-02-21 Takeda Chemical Industries Ltd. Rapidly disintegrable solid preparation
US6224579B1 (en) 1999-03-31 2001-05-01 The Trustees Of Columbia University In The City Of New York Triclosan and silver compound containing medical devices
US6319510B1 (en) 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
EP1054019A1 (en) * 1999-05-18 2000-11-22 Shin-Etsu Chemical Co., Ltd. Low-substituted hydroxypropyl cellulose
US20040215129A1 (en) * 1999-09-16 2004-10-28 Gambro Ab Method and cycler for the administration of a peritoneal dialysis fluid
US6680069B1 (en) 1999-11-09 2004-01-20 Shin-Etsu Chemical Co., Ltd. Low-substituted hydroxypropyl cellulose and process for manufacturing the same
JP3552160B2 (ja) 2000-01-14 2004-08-11 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース粒子の形成方法
US6770297B1 (en) * 2000-05-26 2004-08-03 Unitech Pharmaceuticals, Inc. Controlled release delivery system of solid dosage form
JP3595765B2 (ja) * 2000-09-27 2004-12-02 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤
US7329412B2 (en) 2000-12-22 2008-02-12 The Trustees Of Columbia University In The City Of New York Antimicrobial medical devices containing chlorhexidine free base and salt
WO2002086453A1 (fr) * 2001-04-20 2002-10-31 Sapporo Immuno Diagnostic Laboratory Instrument servant a prelever et a recuperer une secretion liquide d'une cavite orale
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
ATE376826T1 (de) * 2001-09-28 2007-11-15 Mcneil Ppc Inc Darreichungsformen zur modifizierten freisetzung
US7491407B2 (en) * 2001-10-31 2009-02-17 North Carolina State University Fiber-based nano drug delivery systems (NDDS)
US7328706B2 (en) 2002-05-06 2008-02-12 Dynamic Mouth Devices Llc Therapeutic and protective dental device useful as an intra-oral delivery system
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US20040208908A1 (en) * 2003-04-16 2004-10-21 The Trustees Of Columbia University In The City Of New York Antimicrobial medical articles containing a synergistic combination of anti-infective compounds and octoxyglycerin
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
US20060095021A1 (en) * 2004-11-02 2006-05-04 Casas-Bejar Jesus W Introduction of agent with medical device
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
WO2007016676A1 (en) * 2005-08-01 2007-02-08 Teva Pharmaceutical Industries Ltd. Tizanidine compositions and methods of treatment using the compositions
US20070048347A1 (en) * 2005-08-26 2007-03-01 Laura Bardach Intra-oral device for treating obesity
CA2620594C (en) * 2005-09-01 2012-08-21 Eisai R&D Management Co., Ltd. Pharmaceutical composition having improved disintegratability
WO2007070795A2 (en) * 2005-12-12 2007-06-21 The Trustees Of Columbia University In The City Of New York Broad spectrum non-traditional preservative system
US20080044797A1 (en) * 2006-08-15 2008-02-21 Laura Bardach Inserts for use with oral appliances
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
JP2010511627A (ja) * 2006-11-30 2010-04-15 エーシーシーユー−ブレイク テクノロジーズ，インク． 分割可能な浸透性剤形及びその使用方法
US9981069B2 (en) 2007-06-20 2018-05-29 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9687429B2 (en) * 2007-06-20 2017-06-27 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
EP2166840B1 (en) * 2007-06-20 2017-01-11 The Trustees of Columbia University in the City of New York Bio-film resistant surfaces
US9511040B2 (en) 2007-06-20 2016-12-06 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
US20090035228A1 (en) * 2007-08-02 2009-02-05 Shanta Modak Skin and surface disinfectant compositions containing botanicals
US20100172848A1 (en) * 2008-08-01 2010-07-08 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
RU2567723C2 (ru) 2009-07-22 2015-11-10 Грюненталь Гмбх Стабильная при окислении, прочная на излом лекарственная форма
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
WO2012144463A1 (ja) 2011-04-18 2012-10-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 腫瘍治療剤
WO2012166899A2 (en) 2011-06-03 2012-12-06 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
DK2736497T3 (da) 2011-07-29 2017-11-13 Gruenenthal Gmbh Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
US9968101B2 (en) 2011-11-03 2018-05-15 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
WO2013067150A2 (en) 2011-11-03 2013-05-10 The Trustees Of Columbia University In The City Of New York Composition with sustained antimicrobial activity
TW201330856A (zh) 2011-12-06 2013-08-01 Univ Columbia 廣效性的天然防腐組成物
WO2013156453A1 (en) 2012-04-18 2013-10-24 Grünenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9074972B2 (en) 2012-05-16 2015-07-07 Dionex Corporation Surrogate addition device and a method of analyte concentration
US8574400B1 (en) 2012-05-25 2013-11-05 Kimberly-Clark Worldwide, Inc. Tissue comprising macroalgae
US9499941B2 (en) 2012-05-25 2016-11-22 Kimberly-Clark Worldwide, Inc. High strength macroalgae pulps
KR20150098605A (ko) 2012-12-21 2015-08-28 에자이 알앤드디 매니지먼트 가부시키가이샤 퀴놀린 유도체의 비정질 형태 및 그의 제조방법
KR102204279B1 (ko) 2013-05-14 2021-01-15 에자이 알앤드디 매니지먼트 가부시키가이샤 자궁내막암 대상의 렌바티닙 화합물에 대한 반응성을 예측 및 평가하기 위한 생체표지
CA2907950A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
WO2014200455A1 (en) 2013-06-10 2014-12-18 Kimberly-Clark Worldwide, Inc. Layered tissue structures comprising macroalgae
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
RS63559B1 (sr) 2014-08-28 2022-10-31 Eisai R&D Man Co Ltd Derivat hinolina velike čistoće i postupak za njegovu proizvodnju
PL3263106T3 (pl) 2015-02-25 2024-04-02 Eisai R&D Management Co., Ltd. Sposób tłumienia goryczy pochodnej chinoliny
AU2015384801B2 (en) 2015-03-04 2022-01-06 Eisai R&D Management Co., Ltd. Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer
US10575976B2 (en) 2015-04-30 2020-03-03 Dynamic Mouth Devices, L.L.C. Method and apparatus for weight management utilizing an intra-oral device
BR112017027227B1 (pt) 2015-06-16 2023-12-12 Eisai R&D Management Co., Ltd Agente anti-câncer
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations
CN110859997B (zh) * 2018-12-20 2020-06-23 四川大学 具有成骨-抗炎-血糖三维响应结构的牙种植体及其制备方法
US10758329B1 (en) 2019-08-20 2020-09-01 Raymond L. Wright, III Hydrating mouth guard

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3173876A (en) * 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (da) * 1960-11-29
US3276586A (en) * 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) * 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) * 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) * 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4568535A (en) * 1982-08-06 1986-02-04 Loesche Walter J Composition for periodontal administration
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US5021053A (en) * 1989-07-14 1991-06-04 Alza Corporation Oral osmotic device with hydrogel driving member
ATE111351T1 (de) * 1990-07-23 1994-09-15 Alza Corp Oral anzuwendende osmotische vorrichtung zur abgabe von nicotin.

Also Published As

Publication number Publication date
ATE133561T1 (de) 1996-02-15
ES2082626T3 (es) 1996-03-16
WO1993011748A1 (en) 1993-06-24
DE69208104T2 (de) 1996-05-30
US5200194A (en) 1993-04-06
DE69208104D1 (de) 1996-03-14
EP0617611B1 (en) 1996-01-31
ZA929848B (en) 1994-01-13
MX9207402A (es) 1993-07-01
JPH07506806A (ja) 1995-07-27
EP0617611A1 (en) 1994-10-05
AU3333393A (en) 1993-07-19

Similar Documents

Publication Publication Date Title
DK0617611T3 (da) Oral, osmotisk indretning
NO915043L (no) Osmoseanordning for kontrollert avgivelse av et nyttig middel
ATE207374T1 (de) Implantat und applikationsvorrichtung
FI940866A0 (fi) pH-herkällä laukaisimella varustetut, osmoottiset, hajoavat laitteet aineen vapauttamiseksi
EP1138275A3 (en) Multiple solution dental irrigator
EP1767229A3 (en) Expanded PTFE drug delivery graft
NO930134D0 (no) Oral osmoseanordning for avgivelse av nikotin
SE9102539L (sv) Faestningsanordning
GR3001893T3 (en) 2 stage drug delivery device
ES2077757T5 (es) Preparacion farmaceutica solida con disolucion rapida que contiene la n-acetilcisteina.
JP3056825U (ja) 遺体用吸液剤挿入器
JP2000128701A (ja) 遺体からの体液流出防止法
SE9703925D0 (sv) Slanganordning samtanvändning därav
JPH0576417U (ja) 治療器具消毒装置
JPH0318844U (da)
IT1251199B (it) Dispositivo per somministrare nei vasi sanguigni di un paziente sostanze liquide, atto a impedire l'immissione d'aria, in particolare per pazienti sottoposti a emodialisi.